Premature Ejaculation Treatment Market Research Report by Type (Oral Therapies and Topical Therapies) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Premature Ejaculation Treatment Market is expected to grow from USD 2,683.00 Million in 2020 to USD 4,085.88 Million by the end of 2025.
2. The Global Premature Ejaculation Treatment Market is expected to grow from EUR 2,352.50 Million in 2020 to EUR 3,582.58 Million by the end of 2025.
3. The Global Premature Ejaculation Treatment Market is expected to grow from GBP 2,091.38 Million in 2020 to GBP 3,184.92 Million by the end of 2025.
4. The Global Premature Ejaculation Treatment Market is expected to grow from JPY 286,344.09 Million in 2020 to JPY 436,067.44 Million by the end of 2025.
5. The Global Premature Ejaculation Treatment Market is expected to grow from AUD 3,896.07 Million in 2020 to AUD 5,933.24 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Premature Ejaculation Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Premature Ejaculation Treatment Market studied across Oral Therapies and Topical Therapies. The Oral Therapies further studied across Nonselective Serotonin Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor.
Based on Geography, the Premature Ejaculation Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Premature Ejaculation Treatment Market including Absorption Pharmaceuticals, Akorn Pharmaceuticals, Allergan, Bayer, Eli Lilly, Glaxosmithkline, Innovus Pharmaceuticals, Janssen Pharmaceutica N. V, Pfizer, and Plethora Solutions Holdings Plc.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Premature Ejaculation Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Premature Ejaculation Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Premature Ejaculation Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Premature Ejaculation Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Premature Ejaculation Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Premature Ejaculation Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Premature Ejaculation Treatment Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Premature Ejaculation Treatment Market is expected to grow from USD 2,683.00 Million in 2020 to USD 4,085.88 Million by the end of 2025.
2. The Global Premature Ejaculation Treatment Market is expected to grow from EUR 2,352.50 Million in 2020 to EUR 3,582.58 Million by the end of 2025.
3. The Global Premature Ejaculation Treatment Market is expected to grow from GBP 2,091.38 Million in 2020 to GBP 3,184.92 Million by the end of 2025.
4. The Global Premature Ejaculation Treatment Market is expected to grow from JPY 286,344.09 Million in 2020 to JPY 436,067.44 Million by the end of 2025.
5. The Global Premature Ejaculation Treatment Market is expected to grow from AUD 3,896.07 Million in 2020 to AUD 5,933.24 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Premature Ejaculation Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Premature Ejaculation Treatment Market studied across Oral Therapies and Topical Therapies. The Oral Therapies further studied across Nonselective Serotonin Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor.
Based on Geography, the Premature Ejaculation Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Premature Ejaculation Treatment Market including Absorption Pharmaceuticals, Akorn Pharmaceuticals, Allergan, Bayer, Eli Lilly, Glaxosmithkline, Innovus Pharmaceuticals, Janssen Pharmaceutica N. V, Pfizer, and Plethora Solutions Holdings Plc.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Premature Ejaculation Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Premature Ejaculation Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Premature Ejaculation Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Premature Ejaculation Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Premature Ejaculation Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Premature Ejaculation Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Premature Ejaculation Treatment Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET, BY TYPE
6.1. Introduction
6.2. Oral Therapies
6.2.1. Nonselective Serotonin Reuptake Inhibitor
6.2.2. Selective Serotonin Reuptake Inhibitor
6.3. Topical Therapies
7. AMERICAS PREMATURE EJACULATION TREATMENT MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Absorption Pharmaceuticals
11.2. Akorn Pharmaceuticals
11.3. Allergan
11.4. Bayer
11.5. Eli Lilly
11.6. Glaxosmithkline
11.7. Innovus Pharmaceuticals
11.8. Janssen Pharmaceutica N. V
11.9. Pfizer
11.10. Plethora Solutions Holdings Plc
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET, BY TYPE
6.1. Introduction
6.2. Oral Therapies
6.2.1. Nonselective Serotonin Reuptake Inhibitor
6.2.2. Selective Serotonin Reuptake Inhibitor
6.3. Topical Therapies
7. AMERICAS PREMATURE EJACULATION TREATMENT MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Absorption Pharmaceuticals
11.2. Akorn Pharmaceuticals
11.3. Allergan
11.4. Bayer
11.5. Eli Lilly
11.6. Glaxosmithkline
11.7. Innovus Pharmaceuticals
11.8. Janssen Pharmaceutica N. V
11.9. Pfizer
11.10. Plethora Solutions Holdings Plc
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: SCORES
TABLE 41. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: BUSINESS STRATEGY
TABLE 42. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 43. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: RANKING
TABLE 44. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: SCORES
TABLE 41. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: BUSINESS STRATEGY
TABLE 42. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 43. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: RANKING
TABLE 44. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2025
FIGURE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2020 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 55. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PREMATURE EJACULATION TREATMENT MARKET, BY TYPE
FIGURE 1. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2025
FIGURE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, 2020 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 20. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 22. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 27. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 55. GLOBAL PREMATURE EJACULATION TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PREMATURE EJACULATION TREATMENT MARKET, BY TYPE
